Effects of dehydroepiandrosterone sulfate on the conversion of corticosterone into 11-Dehydrocorticosterone in stress: A regulatory scheme

Neuroscience and Behavioral Physiology

Volumn 39, Issue 7, 2009, Pages 695-699

  Obut, T A ^a   Ovsyukova, M V ^a   Dement'eva, T Yu ^a   Cherkasova, O P ^a   Saryg, S K ^a   Grigor'eva, T A ^a  

^a SCIENTIFIC RESEARCH INSTITUTE OF PHYSIOLOGY AND BASIC MEDICINE   (Russian Federation)

Author keywords

opioid receptors; 11 dehydrocorticosterone; Corticosterone; Dehydroepiandrosterone sulfate; Stress

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; DEHYDROCORTICOSTERONE; MU OPIATE RECEPTOR; NALTREXONE; PRASTERONE SULFATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SYNTHESIS; INHIBITION KINETICS; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; STRESS;

ANIMALS; CORTICOSTERONE; DEHYDROEPIANDROSTERONE SULFATE; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; STRESS, PHYSIOLOGICAL;

EID: 68349146408     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-009-9179-6     Document Type: Article

References (13)

1. T. A. Obut, M. V. Ovsyukova, and O. P. Cherkasova, "Effects of dehydroepiandrosterone sulfate on stress reactivity: A μ opiate mechanism," Ros. Fiziol. Zh. im. I. M. Sechenova, 88, No. 12, 1578-1584 (2002).
2. T. A. Obut, M. V. Ovsyukova, and O. P. Cherkasova, "The stress reactivity-limiting effect of dehydroepiandrosterone sulfate and its mechanism," Byull. Éksperim. Biol. Med., 135, No. 3, 269-271 (2003).
3. P. O. Cover and J. C. Buckingham, "Effects of selective opioidreceptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat," J. Endocrinol., 121, 213-220 (1989).
4. M. Homma, T. Onodera, M. Hirabatake, K. Oka, M. Kanazawa, T. Miwa, and T. Hayashi, "Activation of 11 beta-hydroxysteroid dehydrogenase by dehydroepiandrosterone sulfate as an anti-hypertensive agent in spontaneously hypertensive rats," J. Pharm. Pharmacol., 50, 1139-1145 (1998).
5. S. Kapas, A. Purbrick, and J. P. Hinson, "Action of opioid peptides on the rat adrenal cortex: Stimulation of steroid secretion through a specific mu opioid receptor," J. Endocrinol., 144, 503-510 (1995).
6. K. Leung and A. Munck, "Peripheral actions of glucocorticoids," Ann. Rev. Physiol., 37, 245-272 (1975).
7. C. Monder and V. Lakshmi, "Corticosteroid 11 beta-dehydrogenase of rat tissues: Immunological studies," Endocrinology, 126, 2435-2443 (1990).
8. D. J. Morris, A. S. Brem, R. Ge, P. H. Jellinck, R. R. Sasai, and M. P. Hardy, "The functional roles of 11 beta-HSDl: Vascular tissue, testis and brain," Mol. Cell. Endocrinol., 203, 1-12 (2003).
9. K. H. Nwe, A. W. Norhazlina, A. Hamid, P. B. Morat, and B. A. Khalid, "In vivo effects of stress, ACTH and corticosterone on testicular 11 beta-hydroxysteroid dehydrogenase oxidative activity in rats and the possible mechanism of actions," Exp. Clin. Endocrinol. Diabetes, 108, 369-377 (2000).
10. J. R. Seckl, "11Beta-hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action?" Front. Neuroendocrinol., 18, 49-99 (1997).
11. M. Shimojo, J. Conodon, C. B. Whorwood, and P. M. Stewart, "Adrenal 11 beta-hydroxysteroid dehydrogenase," Endocr. Res., 22, 771-780 (1996).
12. B. R. Walker, J. C. Campbell, B. C. Williams, and C. R. Edwards, "Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase," Endocrinology, 131, 970-972 (1992).
13. P. C. White, T. Mure, and A. K. Agarwal, "11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess," Endocr. Rev., 18, 135-156 (1997).